Accelerate Diagnostics (AXDX)
(Delayed Data from NSDQ)
$1.93 USD
+0.01 (0.52%)
Updated Nov 1, 2024 03:59 PM ET
After-Market: $1.93 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth D Momentum D VGM
Industry / Sector Report
Industry : Medical - Instruments
Zacks Industry Rank
Top 32% (79 out of 250)Zacks Sector Rank
Top 19% (3 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.64 | 9.99 |
Current Quarter Estimate | -0.47 | 4.46 | 63.00 |
Year Ago Quarter Estimate | -0.92 | 3.60 | 52.25 |
Next Quarter Estimate | -0.46 | 5.53 | 66.00 |
Next Year Estimate | -1.71 | 24.12 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 56.68 | 14.70 | 15.67 |
Next Year | 20.09 | 19.30 | 11.34 |
Last 5 Years | NA | 10.20 | 8.10 |
Next 5 Years | NA | 12.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | 8.31 |
Price/Book (MRQ) | NA | 2.43 |
Price/Cash Flow (MRFY) | NA | 18.09 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -332.22% | 10.59% |
Return on Equity (TTM) | NA | 12.82% |
Debt to Equity (MRQ) | NA | 39.01 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.